News

T&L Biotechnology: Full‑Chain Exosome Service Solutions
T&L Biotechnology proudly introduces comprehensive exosome services—designed to support every stage of your journey, from extraction and purification to GMP-grade lyophilization.
🌟 What we offer:
✔ Cutting-edge freeze-drying technology for stable, ready-to-use exosome powders.
✔ High-purity solutions with rigorous quality control (>95% purity).
✔ Full-spectrum support tailored to aesthetics, regenerative medicine, and therapeutic innovation.
Discover how our end-to-end solutions empower researchers and businesses to unlock the immense potential of exosomes.
💡 Ready to elevate your project? Explore more here:

From Crisis to Breakthrough: 500-Fold NK Cell Expansion in 17 Days
When a client's Nk Cell culture faced a critical survival crisis—starting with only 47% viability and poor expansion efficiency—T&L Biotechnology's expert team intervened with precision and expertise. In just 17 days, we achieved an incredible 500-fold expansion and a 90.8% positive rate. Here's how we did it.

AMMS® High Purity NK Cell Culture Kit 3.0 Now Available | Say Goodbye to Sample Variability—Achieve ≥ 95 % NK Purity!
🔬 Our new AMMS® High Purity NK Cell Culture Kit 3.0 delivers ≥ 95 % NK purity in just 20 minutes—with real data to prove it!
🚀 Ready to boost your research reliability?
👉 Click to discover more!

New Product Launch: Recombinant Human TPO Protein—A Breakthrough in Hematopoietic Regulation and Stem Cell Culture Innovation!
✅ Core Advantages
✓ 5x Higher Bioactivity (Validated with Mo7e cells)
✓ Ultra-High Purity >90% (SDS-PAGE Certified)
✓ Low Endotoxin <1.0 EU/μg
🔬 Applications
▸ Cord Blood HSC Expansion
▸ In Vitro Drug Screening Platforms
▸ Bone Marrow Failure Research
📊 Data Highlights
⭐ 3-fold Increase in CFU with SCF/IL-3 Synergy
⭐ Maintains HSC Quiescence for 72h+

ASGCT2025 Countdown | T&L Biotechnology Debuts New Products in New Orleans, On-site Consultations with Tech Experts, Plus Surprise Games to Unlock!
🚀 We're off to New Orleans—see you at T&L Biotechnology's booth!

The Repair Champion in High-Temperature Environments! T&L Biotechnology Officially Launches New-Generation Thermostable bFGF Protein
Basic Fibroblast Growth Factor (bFGF) is indispensable for cell growth and Stem Cell pluripotency maintenance but is limited by instability under physiological conditions. T&L Biotechnology's Thermostable Recombinant Human bFGF Protein overcomes these challenges with enhanced thermal stability, maintaining biological activity across diverse conditions. Ideal for hESC and iPSC culture, it supports cost-efficient workflows with reduced medium replacement frequency.
Key Features
✔️ Thermostable: Enhanced stability for prolonged activity
✔️ High Purity & Activity: Ensures reproducible results
✔️ Cost-Effective: Reduces supplementation frequency
✔️ Sterile & Mycoplasma-Free: Supports safe, reliable research

Now Available!|Research-Grade ActCel T Cell Activation Reagent – Free Trials for New Product
T Cells play a crucial role in our immune system, and T cell therapies are breaking ground in treating challenging diseases like cancer and autoimmune disorders. A key step in T cell therapy,T cell activation, directly impacts therapeutic outcomes. That’s why we're excited to introduce our ActCel T Cell Activation Reagent (Cat. No. TL-6001-1000) — designed for gentle, efficient activation to support high cell viability and expansion.
Key Features
✔️ Safe and Effective: Gentle activation for robust cell expansion
✔️ Easy to Use: Ready-to-use format
✔️ Cost-Effective: Reliable performance with competitive pricing

Our Latest Webinar: "Understanding Autoimmune CAR-T Therapy"
Autoimmune diseases are a global health challenge, affecting nearly 10% of the population. But what if I told you there's a potential breakthrough in treating these conditions?
We're excited to share our latest webinar, " Understanding Autoimmune CAR-T Therapy," featuring Dr. Allan Zhang. In this insightful session, Dr. Zhang explores the cutting-edge of CAR-T technology and its application in autoimmune diseases, offering hope for drug-free remission.

Meet Us at the ESGCT Congress in Rome!
We are delighted to announce that T&L Biotechnology will be participating in the 31st Annual ESGCT Congress, a premier event in gene and cell therapy.
Don't miss this chance to be part of a transformative event. For more information or to set up a meeting, please contact us directly. We are excited to welcome you to our booth and discuss how T&L Biotechnology can be a valuable partner in your scientific journey.
See you in Rome!

The First Step of CAR-T Commercialization
As a new method of individualized tumor immunotherapy, CAR-T cell therapy has shown great therapeutic potential. However, commercial operation means new challenges. Compared with traditional chemicals, "living" biopharmaceuticals have greater uncertainty, potential problems...
